UBS AM’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
UBS AM's IPSC Position: Q3 2026 in Review
UBS AM opened a new position in Century Therapeutics (IPSC) in Q3 2026: 40 shares worth $68. The stake represents ﹤0.01% of the portfolio and ranks #4231 among its holdings.
74 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- UBS AM held 40 shares of Century Therapeutics worth $68 as of Q3 2026.
- Century Therapeutics was a new UBS AM position in Q3 2026.
- Century Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4231 holding.
- 74 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.